Tags

Type your tag names separated by a space and hit enter

WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015.
Vaccine. 2018 06 07; 36(24):3421-3422.V

Abstract

This article presents the World Health Organization's (WHO) updated recommendations on the use of meningococcal vaccines excerpted from the WHO position paper on Meningococcal A conjugate vaccine: updated guidance, February 2015, published in the Weekly Epidemiological Record [1]. A position paper on meningococcal vaccines was published in 2011 and its recommendations remain valid [2]. This update adds to the previous recommendations specifically concerning routine immunization of infants and young children in the African meningitis belt with meningococcal A conjugate vaccine. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of the Meningococcal A conjugate vaccine were discussed by SAGE in October 2014; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2014/october/presentations_background_docs/en/.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28760613

Citation

World Health Organization, . "WHO Position Paper, Meningococcal a Conjugate Vaccine: Updated Guidance, February 2015." Vaccine, vol. 36, no. 24, 2018, pp. 3421-3422.
World Health Organization . WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015. Vaccine. 2018;36(24):3421-3422.
World Health Organization, . (2018). WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015. Vaccine, 36(24), 3421-3422. https://doi.org/10.1016/j.vaccine.2017.07.063
World Health Organization . WHO Position Paper, Meningococcal a Conjugate Vaccine: Updated Guidance, February 2015. Vaccine. 2018 06 7;36(24):3421-3422. PubMed PMID: 28760613.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015. A1 - World Health Organization,, Y1 - 2017/07/29/ PY - 2017/04/28/received PY - 2017/07/19/accepted PY - 2017/8/2/pubmed PY - 2018/9/27/medline PY - 2017/8/2/entrez KW - Meningococcal A conjugate vaccine KW - Meningococcal vaccines KW - Position paper KW - SAGE KW - Updated recommendation KW - World Health Organization (WHO) SP - 3421 EP - 3422 JF - Vaccine JO - Vaccine VL - 36 IS - 24 N2 - This article presents the World Health Organization's (WHO) updated recommendations on the use of meningococcal vaccines excerpted from the WHO position paper on Meningococcal A conjugate vaccine: updated guidance, February 2015, published in the Weekly Epidemiological Record [1]. A position paper on meningococcal vaccines was published in 2011 and its recommendations remain valid [2]. This update adds to the previous recommendations specifically concerning routine immunization of infants and young children in the African meningitis belt with meningococcal A conjugate vaccine. Footnotes to this paper provide a number of core references including references to grading tables that assess the quality of the scientific evidence. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. Recommendations on the use of the Meningococcal A conjugate vaccine were discussed by SAGE in October 2014; evidence presented at these meetings can be accessed at: http://www.who.int/immunization/sage/meetings/2014/october/presentations_background_docs/en/. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/28760613/WHO_position_paper_Meningococcal_A_conjugate_vaccine:_Updated_guidance_February_2015_ DB - PRIME DP - Unbound Medicine ER -